Efficacy of bevacizumab (BV) plus docetaxel (D) does not correlate with hypertension (HTN) or G-CSF use in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) in the AVAIDO phase III study

A Chan (Author)
L Vanlemmens (Author)
PF Conte (Author)
J Beith (Author)
Hellmut Samonigg (Author)
S Verma (Author)
V Srimuninnimit (Author)
A Martoni (Author)
DW Miles (Author)

Division of Oncology

Activity: Talk, presentation or poster › Poster

Period	2009
Event title	31st Annual San Antonio Breast Cancer Symposium
Event type	Conference
Location	San Antonio, United StatesShow on map
Degree of Recognition	International

Related content

Publications
Efficacy of bevacizumab (BV) plus docetaxel (D) does not correlate with hypertension (HTN) or G-CSF use in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) in the AVAIDO phase III study
Research output: Contribution to journal › Conference abstract